Free Trial
OTCMKTS:NSTM

NovelStem International 8/14/2024 Earnings Report

NovelStem International logo
$0.03 0.00 (0.00%)
As of 06/13/2025

NovelStem International EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NovelStem International Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NovelStem International Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NovelStem International Earnings Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
Glencore International
See More NovelStem International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NovelStem International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovelStem International and other key companies, straight to your email.

About NovelStem International

NovelStem International (OTCMKTS:NSTM), a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

View NovelStem International Profile

More Earnings Resources from MarketBeat